Pancreatic cancer

Pancreatic cancer

Gastroenterology and Metabolism

Gastroenterology and Metabolism

Abdominal pain: Clinical
Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Esophagitis: Clinical
Esophageal disorders: Clinical
Esophageal surgical conditions: Clinical
Esophageal cancer
Acid reducing medications
Esophageal disorders: Pathology review
Gastrointestinal bleeding: Clinical
Gastrointestinal bleeding: Pathology review
Pediatric gastrointestinal bleeding: Clinical
Peptic ulcers and stomach cancer: Clinical
Zollinger-Ellison syndrome
Pancreatic neuroendocrine neoplasms
Helicobacter pylori
Peptic ulcer
Gastric cancer
Gastric motility
Malabsorption syndromes: Pathology review
Malabsorption: Clinical
Short bowel syndrome (NORD)
Celiac disease
Celiac disease: Nursing process (ADPIE)
Lactose intolerance
Small bowel ischemia and infarction
Superior mesenteric artery syndrome
Inflammatory bowel disease: Pathology review
Inflammatory bowel disease: Clinical
Diverticulosis and diverticulitis
Laxatives and cathartics
Diverticular disease: Pathology review
Elimination disorders: Clinical
Volvulus
Irritable bowel syndrome
Bowel obstruction
Antidiarrheals
Ulcerative colitis
Crohn disease
Colorectal polyps
Colorectal polyps and cancer: Pathology review
Juvenile polyposis syndrome
Familial adenomatous polyposis
Peutz-Jeghers syndrome
Colorectal cancer: Clinical
Colorectal cancer
Anal conditions: Clinical
Acute pancreatitis
Pancreatitis: Pathology review
Pancreatitis: Clinical
Chronic pancreatitis
Pancreatic cancer
Viral hepatitis
Viral hepatitis: Clinical
Hepatitis medications
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Hepatitis C virus
Viral hepatitis: Pathology review
Autoimmune hepatitis
Primary biliary cholangitis
Primary sclerosing cholangitis
Jaundice: Pathology review
Alcohol-associated liver disease
Cirrhosis: Pathology review
Cirrhosis
Cirrhosis: Clinical
Portal hypertension
Wilson disease
Hemochromatosis
Hepatocellular carcinoma
Benign liver tumors
Non-alcoholic fatty liver disease
Liver anatomy and physiology
Acute cholecystitis
Chronic cholecystitis
Gallbladder disorders: Pathology review
Gallbladder disorders: Clinical
Biliary colic
Gallbladder carcinoma
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Acute intermittent porphyria
Vitamin D
Osteomalacia and rickets
Major depressive disorder with seasonal pattern
Hypercalcemia
Hypocalcemia
Parathyroid conditions and calcium imbalance: Clinical
Bone disorders: Pathology review
Osteoporosis
Iron deficiency anemia
Metabolic acidosis
Respiratory acidosis
Renal tubular acidosis: Pathology review
Metabolic and respiratory acidosis: Clinical
Acid-base disturbances: Pathology review
Metabolic alkalosis
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Hypernatremia
Hypernatremia: Clinical
Hyponatremia
Hyponatremia: Clinical
Hyperkalemia
Hyperkalemia: Clinical
Hypokalemia: Clinical
Hypokalemia
Electrolyte disturbances: Pathology review
Phosphate, calcium and magnesium homeostasis
Hypomagnesemia
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Dyslipidemias: Pathology review
Gout
Gout and pseudogout: Pathology review
Bacteroides fragilis

Transcript

Watch video only

Content Reviewers

Pancreatic carcinoma describes the pancreas having cancerous cells arise.

Now a healthy pancreas has two types of glands, exocrine glands which sends digestive enzymes off to the small intestine, and endocrine glands which help regulate metabolism in the body, for example, maintaining normal blood sugar.

Over 95% of pancreatic tumors develop in the pancreas’s exocrine tissues, and of these, tumors arising in the epithelial cells lining the pancreatic ducts account for the vast majority of cases.

This type of pancreatic cancer is known as pancreatic adenocarcinoma due to the cells glandular-like (“adeno”) appearance under the microscope, often pancreatic adenocarcinoma is used interchangeably with pancreatic carcinoma.

These tumors typically form in the head or neck of the pancreas, but in some cases tumors form in the tail.

Around 5% of exocrine pancreatic carcinomas are caused by malignancies in the acinar cells, which are the cells that produce the digestive enzymes like trypsinogen, and around 1% are cystadenocarcinomas, or malignant cysts.

There are also other types of pancreatic cancer, but those are even more rare.

Generally, pancreatic carcinoma is caused by genetic mutations in the ductal epithelial cells, and these mutations might activate oncogenes which promote cancer or inactivate tumor suppressor genes.

Either way, this can lead to uncontrolled cell growth caused by the disruptions of the cell signalling pathways that regulate cell survival and growth, as well as multiple immune system responses like inflammation and stress responses.

Although it’s not exactly clear how the genetic mutations that trigger pancreatic carcinoma develop, there are some well known modifiable risk factors like smoking which increases the risk by two to five-fold, obesity, as well as eating a diet high in red meat.

There are also some non-modifiable risk factors like being male, being African American, and being over 65 years old.

Also, certain other diseases seem to increase the risk of developing pancreatic carcinoma as well, like diabetes, chronic pancreatitis, and liver cirrhosis, all of which are linked to excessive alcohol consumption, so there does seem to be an indirect relationship between pancreatic carcinoma and alcohol as well.

Finally, a family history of pancreatic cancer is also an important risk factor that increases individual risk, with inherited mutations in BRCA2, or breast cancer gene 2 being the most common cause of inherited pancreatic carcinoma, and mutations in PALB2 taking second place.

Initially symptoms are often vague, like nausea, vomiting, and fatigue.

There might also be weight loss, which may be due to cancer-associated anorexia, or malabsorption due to an obstructed pancreatic duct which can cause steatorrhea, foul-smelling greasy loose stools.

One of the most specific symptoms of pancreatic carcinoma is midepigastric pain that radiates to the mid- or lower-back, which often hurts the most at night when the individual is lying down flat.

Other classic symptoms that have been described include Trousseau sign, which is when blood clots, that can be felt as small lumps under the skin, appear unexpectedly in superficial veins, and then over time, migrate to different locations.

As well as Courvoisier sign, which is when the gallbladder is enlarged and palpable, and the patient does not find it at all tender to the touch, which is unlike gallstones. This occurs when the common bile duct is blocked by a tumor so this sign suggests the tumor is more likely in the head of the pancreas than the tail.

Key Takeaways

Pancreatic cancer is an aggressive tumor arising from the pancreatic duct mostly of the head or neck. The most common type of pancreatic cancer is pancreatic adenocarcinoma. Symptoms of pancreatic cancer can include abdominal pain radiating to the back, weight loss, jaundice, loss of appetite, nausea, and fatigue.

Pancreatic cancer is caused by genetic mutations in the ductal epithelial cells, which activate oncogenes that promote cancer or inactivate tumor suppressor genes. The risk factors include smoking, a family history of pancreatic cancer, and certain medical conditions such as diabetes and pancreatitis. Treatment for pancreatic cancer may include surgery, chemotherapy, or radiotherapy, depending on the stage of cancer and the patient's overall health.